Robert S. Negm
Corporate Officer/Principal chez Gentel Biosciences, Inc.
Profil
Robert S.
Negm is Vice President of Business Development for Gentel Biosciences, Inc. He joined Gentel in 2005.
Dr. Negm served as Director of Business Development at Schleicher and Schuell BioScience.
He was a Program Director for the National Cancer Institute from 1998 to 2001.
Dr. Negm received a PhD in Microbiology and a BS degree in Biochemistry from the University of New Hampshire.
Postes actifs de Robert S. Negm
| Sociétés | Poste | Début |
|---|---|---|
Gentel Biosciences, Inc.
 Gentel Biosciences, Inc. Medical SpecialtiesHealth Technology Gentel Biosciences, Inc. develops and distributes biochip and protein microarray tests. It provides protein microarray products and services to life science researchers worldwide. The company was founded by Llloyd Smith and Kenneth U. Johnson in 2000 and is headquartered in Madison, WI. | Corporate Officer/Principal | 01/01/2005 |
Anciens postes connus de Robert S. Negm
| Sociétés | Poste | Fin |
|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Directeur/Membre du Conseil | 01/01/2001 |
| Schleicher & Schuell Beteiligungs GmbH | Corporate Officer/Principal | - |
Formation de Robert S. Negm
| University of New Hampshire | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| Schleicher & Schuell Beteiligungs GmbH | Producer Manufacturing |
Gentel Biosciences, Inc.
Gentel Biosciences, Inc. Medical SpecialtiesHealth Technology Gentel Biosciences, Inc. develops and distributes biochip and protein microarray tests. It provides protein microarray products and services to life science researchers worldwide. The company was founded by Llloyd Smith and Kenneth U. Johnson in 2000 and is headquartered in Madison, WI. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |